Clinical Coagulation, Malmö
631 – 640 of 659
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 1998
-
Mark
The A20210 allele of the prothrombin gene is frequently associated with the factor V Arg 506 to Gln mutation but not with protein S deficiency in thrombophilic families
- Contribution to journal › Letter
-
Mark
The A20210 allele of the prothrombin gene is frequently associated with the factor V Arg 506 to Gln mutation but not with protein S deficiency in thrombophilic families [3]
- Contribution to journal › Letter
-
Mark
Major surgery seems not to influence HIV disease progression in haemophilia patients
- Contribution to journal › Article
- 1997
-
Mark
No effect of a new second-generation B-domain-deleted recombinant product on lymphocyte transformation in vitro: a study of plasma-derived and recombinant products
- Contribution to journal › Article
-
Mark
Age relations of cardiovascular risk factors in a traditional Melanesian society: the Kitava Study
- Contribution to journal › Article
-
Mark
Resistance to activated protein C a novel risk factor for venous thrombosis
(1997)
- Thesis › Doctoral thesis (compilation)
-
Mark
Pharmacokinetic dosing of factor VIII and factor IX in prophylactic treatment of haemophilia
(1997)
- Thesis › Doctoral thesis (compilation)
-
Mark
The 20210 A allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep venous thrombosis
- Contribution to journal › Debate/Note/Editorial
-
Mark
The factor VR506Q mutation causing APC resistance is highly prevalent amongst unselected outpatients with clinically suspected deep venous thrombosis
- Contribution to journal › Article
-
Mark
Evaluation of original and modified APC-resistance tests in unselected outpatients with clinically suspected thrombosis and in healthy controls
- Contribution to journal › Article
